Literature DB >> 30972798

Medical Algorithms: Diagnosis and treatment of Hymenoptera venom allergy.

Gunter J Sturm1,2, Lisa Arzt-Gradwohl1, Eva-M Varga3.   

Abstract

Diagnosis of Hymenoptera venom allergy (HVA) is straightforward in the majority of patients, but can be challenging in double positive and test negative patients. Test results sometimes can be confusing as patients with high skin test reactivity and high specific IgE (sIgE) levels are not at risk for severe systemic sting reactions (SSR), and conversely, patients with weakly positive or even negative tests can experience severe SSR. Venom immunotherapy (VIT) is safe, highly effective, and recommended in patients with moderate to severe SSR and in patients with SSR confined to generalized skin symptoms if quality of life is impaired.
© 2019 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

Entities:  

Keywords:  allergy diagnosis; hymenoptera venom allergy; insect venom allergy; venom immunotherapy

Year:  2019        PMID: 30972798     DOI: 10.1111/all.13817

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  4 in total

Review 1.  Acute Urticaria and Anaphylaxis: Differences and Similarities in Clinical Management.

Authors:  Luis Felipe Ensina; Taek Ki Min; Mara Morelo Rocha Félix; Carolina Tavares de Alcântara; Célia Costa
Journal:  Front Allergy       Date:  2022-04-15

2.  Adverse reactions in venom immunotherapy protocols: conventional versus ultra-rush.

Authors:  Ali Selcuk; Abdullah Baysan; Sait Yesillik; Fevzi Demirel; Ozgur Kartal; Mustafa Gulec; Ugur Musabak; Osman Sener
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

Review 3.  Apitoxin and Its Components against Cancer, Neurodegeneration and Rheumatoid Arthritis: Limitations and Possibilities.

Authors:  Andreas Aufschnaiter; Verena Kohler; Shaden Khalifa; Aida Abd El-Wahed; Ming Du; Hesham El-Seedi; Sabrina Büttner
Journal:  Toxins (Basel)       Date:  2020-01-21       Impact factor: 4.546

4.  Component-Resolved Evaluation of the Risk and Success of Immunotherapy in Bee Venom Allergic Patients.

Authors:  Marta Rosiek-Biegus; Robert Pawłowicz; Agnieszka Kopeć; Magdalena Kosińska; Marta Wrześniak; Marita Nittner-Marszalska
Journal:  J Clin Med       Date:  2022-03-17       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.